ZNF335 anticorps (Middle Region)
Aperçu rapide pour ZNF335 anticorps (Middle Region) (ABIN927822)
Antigène
Voir toutes ZNF335 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Réactivité croisée
- Rat (Rattus), Boeuf (Vache), Chien
-
Purification
- Purified
-
Immunogène
- ZNF335 antibody was raised in rabbit using the middle region of ZNF335 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
ZNF335 Blocking Peptide, (ABIN937634), is also available for use as a blocking control in assays to test for specificity of this ZNF335 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ZNF335 (Zinc Finger Protein 335 (ZNF335))
-
Autre désignation
- ZNF335
-
Sujet
- ZNF335 enhances transcriptional activation by ligand-bound nuclear hormone receptors. However, it does this not by direct interaction with the receptor, but by direct interaction with the nuclear hormone receptor transcriptional coactivator NRC. ZNF335 may function by altering local chromatin structure.The protein encoded by this gene enhances transcriptional activation by ligand-bound nuclear hormone receptors. However, it does this not by direct interaction with the receptor, but by direct interaction with the nuclear hormone receptor transcriptional coactivator NRC. The encoded protein may function by altering local chromatin structure. Synonyms: Polyclonal ZNF335 antibody, Anti-ZNF335 antibody, zinc finger protein 335 antibody, NIF1 antibody.
Antigène
-